The SSI Mantra 3 has been put in in 75 hospitals world wide up to now. | Supply: SS Improvements Worldwide
SS Improvements Worldwide Inc. at present introduced that it has accomplished its first robotic cardiac surgical procedure within the Americas with its SSi Mantra 3 surgical robotic system.
On June 8, Dr. Juan Zuniga, a cardiothoracic surgeon at Interhospital in Guayaquil, Ecuador, turned the primary surgeon to carry out a robotic cardiac surgical procedure within the Americas and Western Hemisphere utilizing the SSi Mantra 3. The surgical procedure concerned a robotic Atrial Septal Defect closure. This process repairs a gap between the higher two chambers of the guts.
“On the heels of SSi Mantra’s debut in Latin American robotic surgical procedures, we determined to leverage this superior system in advanced specialties, significantly in cardiovascular surgical procedures,” Dr. Zuniga mentioned.
“The expertise was good, this tools was very straightforward to deal with and manipulate, and the outcomes had been efficient as we did a transesophageal echocardiogram to confirm the entire closure of the communication between the 2 higher chambers of the guts,” he mentioned. “We had been very proud of the leads to reaching a profitable closure, and the affected person is recovering very effectively.”
SSi Mantra aids minimally invasive procedures
Interhospital is the primary hospital in South America to put in the SSi Mantra. It has carried out a wide range of advanced surgical procedures with the surgical robotic system since its set up.
“As a result of it’s a minimally invasive process, the restoration is far sooner, bleeding a lot much less, and since it’s performed robotically, the manipulation of the tissues is rather more exact, and so is the suturing,” added Dr. Zuniga. “It provides the surgeon the boldness that each sew that’s made with the platform is positioned exactly and with out complication.”
SS Improvements described the SSi Mantra as “a user-friendly, modular, multi-arm system.” Its expertise options embody:
- Three to 5 modular robotic arms
- An open-faced ergonomic surgeon command heart
- A big 3D 4K monitor
- A contact panel monitor for all patient-related data shows
- A digital real-time picture of the robotic patient-side arm carts
- The power to superimpose 3D fashions for diagnostic imaging
A imaginative and prescient cart offers the table-side group with the identical magnified 3D 4K view because the surgeon to supply higher security and effectivity. The SSi Mantra makes use of greater than 40 sorts of robotic endo-surgical devices to help totally different specialties, together with cardiac surgical procedure. The system has additionally been clinically validated in India, mentioned SS Improvements.
Now accepting session submissions!
SS Improvements surpasses 4,000 robotic surgical procedures
Final month, SS Improvements introduced that SSi Mantra has been utilized in 4,000 surgical procedures. These operations spanned greater than 100 various kinds of surgical procedures with none issues, accidents, or mortalities.
The Fort Lauderdale, Fla.-based firm famous this included roughly 215 cardiac surgical procedures. Six of those had been efficiently carried out by way of telesurgery throughout India with the SSi Mantra 3 surgical robotic system.
The Robotic Report beforehand mentioned SS Improvements’ telesurgery technique with Dr. Vishwa Srivastava, chief working officer and chairman of the board.
SS Improvements mentioned it has developed techniques to make robotic surgical procedure inexpensive and accessible to a bigger phase of the worldwide inhabitants. The corporate’s product vary contains its proprietary SSi Mantra and its complete suite of SSi Mudra devices, which help a wide range of surgical procedures.
The corporate launched its newest system, the SSi Mantra 3, in July 2024. The system obtained regulatory approval for distant surgical procedure and teleproctoring from the Central Medication Normal Management Group (CDSCO). This opens the door for distant surgical procedures and medical schooling.
In Could 2025, SS Improvements revealed plans to submit a de novo classification request to the U.S. Meals and Drug Administration for the system.
